
CAS 1923844-48-7
:Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
Description:
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]- is a chemical compound characterized by its complex structure, which includes a benzamide moiety and a chloro substituent. The presence of a fluorinated quinoline ring contributes to its potential biological activity, particularly in medicinal chemistry. The compound features a cyclohexyl group that is substituted with an ethyl chain, indicating a degree of steric hindrance that may influence its interaction with biological targets. The chirality at the (1R) position suggests that the compound exists as a specific enantiomer, which can significantly affect its pharmacological properties. This compound may exhibit properties such as lipophilicity due to the aromatic and aliphatic components, which can influence its solubility and permeability in biological systems. Overall, the unique combination of functional groups and structural features positions this compound as a candidate for further investigation in drug development and therapeutic applications.
Formula:C24H24ClFN2O
Synonyms:- BMS-986242
- Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
BMS-986242
CAS:BMS-986242 is an orally active, potent and selective inhibitor of indoleamine-2,3-dioxygenase 1 (IDO1), and it can be used for the research of cancer.Formula:C24H24ClFN2OPurity:98.9%Color and Shape:SolidMolecular weight:410.91BMS-986242
CAS:BMS-986242 is a potent inhibitor of protein kinases that have been implicated in tumor growth and progression. It has demonstrated anticancer activity by inhibiting the cyclin-dependent kinase (CDK) pathway, which is essential for cell cycle progression and survival. BMS-986242 has been shown to induce apoptosis in human cancer cells, including Chinese hamster ovary cells. This inhibitor has potential as a medicinal compound for the treatment of various types of cancer. Its specificity towards protein kinases makes it a promising candidate for targeted therapies against cancer.Formula:C24H24ClFN2OPurity:Min. 95%Molecular weight:410.9 g/mol


